Biphasic recruitment of microchimeric fetal mesenchymal cells in fibrosis following acute kidney injury

Kidney International

Volumn 85, Issue 3, 2014, Pages 600-610

  Roy, Edwige ^a   Seppanen, Elke ^a   Ellis, Rebecca ^a   Lee, Eddy S ^a   Khosroterani, Kiarash ^a   Fisk, Nicholas M ^a,b   Bou Gharios, George ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

aristolochic acid; fetal microchimerism; mesenchymal cells; nephropathy; renal interstitial fibrosis

Indexed keywords

ARISTOLOCHIC ACID; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UREA; GREEN FLUORESCENT PROTEIN; LUCIFERASE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BIPHASIC RECRUITMENT; CELL ACTIVITY; CELL FUNCTION; CELL LINEAGE; CELL REGENERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FETAL MICROCHIMERIC CELL; FETUS; FIBROBLAST; HEMATOPOIETIC CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; MALE; MESENCHYME CELL; MICROCHIMERISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; UREA BLOOD LEVEL; FETAL MICROCHIMERIC MESENCHYMAL CELL; IN VIVO STUDY; MOTHER; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PUERPERIUM; TISSUE REPAIR; WILD TYPE; ANIMAL; C57BL MOUSE; CELL MOTION; CHIMERA; CYTOLOGY; EMBRYOLOGY; FIBROSIS; HEMATOPOIESIS; KIDNEY; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CELL MOVEMENT; CHIMERISM; FEMALE; FETUS; FIBROSIS; HEMATOPOIESIS; KIDNEY; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL;

EID: 84895162430     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.459     Document Type: Article

References (61)

1. Bianchi DW, Zickwolf GK, Weil GJ et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705-708
2. Krabchi K, Gros-Louis F, Yan J et al. Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques. Clin Genet 2001; 60: 145-150
3. Maloney S, Smith A, Furst DE et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104: 41-47
4. Khosrotehrani K, Johnson KL, Cha DH et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004; 292: 75-80
5. Khosrotehrani K, Leduc M, Bachy V et al. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol 2008; 180: 889-897
6. Roy E, Leduc M, Guegan S et al. Specific maternal microchimeric T cells targeting fetal antigens in beta cells predispose to auto-immune diabetes in the child. J Autoimmun 2011; 36: 253-262
7. Santos MA, ODonoghue K, Wyatt-Ashmead J et al. Fetal cells in the maternal appendix: a marker of inflammation or fetal tissue repair? Hum Reprod 2008; 23: 2319-2325
8. Dubernard G, Aractingi S, Oster M et al. Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 2008; 10: R14
9. Bou-Gharios G, Amin F, Hill P et al. Microchimeric fetal cells are recruited to maternal kidney following injury and activate collagen type I transcription. Cells Tissues Organs 2011; 193: 379-392
10. Nguyen HS, Dubernard G, Aractingi S et al. Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev 2006; 2: 111-116
11. Nguyen K, Eltz S, Drouin SJ et al. Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience. World J Urol 2009; 27: 653-658
12. Nassar D, Khosrotehrani K, Aractingi S. Fetal microchimerism in skin wound healing. Chimerism 2012; 3: 45-47
13. Zeng XX, Tan KH, Yeo A et al. Pregnancy-Associated progenitor cells differentiate and mature into neurons in the maternal brain. Stem Cells Dev 2010; 19: 1819-1830
14. Wang Y, Iwatani H, Ito T et al. Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004; 325: 961-967
15. Nelson JL, Furst DE, Maloney S et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998; 351: 559-562
16. Guetta E, Gordon D, Simchen MJ et al. Hematopoietic progenitor cells as targets for non-invasive prenatal diagnosis: detection of fetal CD34+ cells and assessment of post-delivery persistence in the maternal circulation. Blood Cells Mol Dis 2003; 30: 13-21
17. Liegeois A, Gaillard MC, Ouvre E et al. Microchimerism in pregnant mice. Transplantation proceedings 1981; 13: 1250-1252
18. Walknowska J, Conte FA, Grumbach MM. Practical and theoretical implications of fetal-maternal lymphocyte transfer. Lancet 1969; 1: 1119-1122
19. Nguyen HS, Oster M, Avril MF et al. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy. Am J Pathol 2009; 174: 630-637
20. Parant O, Dubernard G, Challier JC et al. CD34+ cells in maternal placental blood are mainly fetal in origin and express endothelial markers. Lab Invest 2009; 89: 915-923
21. Guettier C, Sebagh M, Buard J et al. Male cell microchimerism in normal and diseased female livers from fetal life to adulthood. Hepatology 2005; 42: 35-43
22. Cha D, Khosrotehrani K, Kim Y et al. Cervical cancer and microchimerism. Obstet Gynecol 2003; 102: 774-781
23. Chan J, ODonoghue K, Gavina M et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 2006; 24: 1879-1891
24. ODonoghue K, Choolani M, Chan J et al. Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis. Mol Hum Reprod 2003; 9: 497-502
25. Kennea NL, Waddington SN, Chan J et al. Differentiation of human fetal mesenchymal stem cells into cells with an oligodendrocyte phenotype. Cell Cycle 2009; 8: 1069-1079
26. Sato N, Takahashi D, Chen SM et al. Acute nephrotoxicity of aristolochic acids in mice. J Pharmacy Pharmacol 2004; 56: 221-229
27. Fragiadaki M, Witherden AS, Kaneko T et al. Interstitial fibrosis is associated with increased COL1A2 transcription in AA-injured renal tubular epithelial cells in vivo. Matrix Biol 2011; 30: 396-403
28. Lebeau C, Debelle FD, Arlt VM et al. Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies. Nephrol Dial Transplant 2005; 20: 2321-2332
29. Lewis MP, Norman JT. Differential response of activated vs. non-Activated renal fibroblasts to tubular epithelial cells: a model of initiation and progression of fibrosis? Exp Nephrol 1998; 6: 132-143
30. Eddy AA, Neilson EG. Chronic kidney disease progression. J Am Soc Nephrol 2006; 17: 2964-2966
31. Togel F, Isaac J, Hu Z et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772-1784
32. Semedo P, Wang PM, Andreucci TH et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc 2007; 39: 421-423
33. Caldas HC, Fernandes IM, Gerbi F et al. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant Proc 2008; 40: 853-855
34. Khosrotehrani K, Bianchi DW. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Science 2005; 118: 1559-1563
35. Nassar D, Droitcourt C, Mathieu-dArgent E et al. Fetal progenitor cells naturally transferred through pregnancy participate in inflammation and angiogenesis during wound healing. FASEB J 2012; 26: 149-157
36. Pozdzik AA, Salmon IJ, Debelle FD et al. Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int 2008; 73: 595-607
37. Zhou L, Fu P, Huang XR et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3. Am J Physiol Renal Physiol 2010; 298: F1006-F1017
38. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783-2810
39. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18: 816-827
40. Witzgall R, Brown D, Schwarz C et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994; 93: 2175-2188
41. Rumberger B, Vonend O, Kreutz C et al. cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain. Kidney Blood Press Res 2007; 30: 377-387
42. Lin SL, Castano AP, Nowlin BT et al. Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 2009; 183: 6733-6743
43. Panek AN, Posch MG, Alenina N et al. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One 2009; 4: e6743
44. Yokoi H, Mukoyama M, Mori K et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int 2008; 73: 446-455
45. Srivatsa B, Srivatsa S, Johnson KL et al. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 2001; 358: 2034-2038
46. Evans PC, Lambert N, Maloney S et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999; 93: 2033-2037
47. Li W, Ferkowicz MJ, Johnson SA et al. Endothelial cells in the early murine yolk sac give rise to CD41-expressing hematopoietic cells. Stem Cells Dev 2005; 14: 44-54
48. Roufosse C, Bou-Gharios G, Prodromidi E et al. Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis. J Am Soc Nephrol 2006; 17: 775-782
49. Archdeacon P, Detwiler RK. Bone morphogenetic protein 7 (BMP7): a critical role in kidney development and a putative modulator of kidney injury. Adv Chronic Kidney Dis 2008; 15: 314-320
50. Carev D, Saraga M, Saraga-Babic M. Involvement of FGF and BMP family proteins and VEGF in early human kidney development. Histol Histopathol 2008; 23: 853-862
51. Barisic-Dujmovic T, Boban I, Clark SH. Fibroblasts/myofibroblasts that participate in cutaneous wound healing are not derived from circulating progenitor cells. J Cell Physiol 2010; 222: 703-712
52. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858-870
53. Forbes JM, Hewitson TD, Becker GJ et al. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int 2000; 57: 2375-2385
54. Macedo E, Bouchard J, Mehta RL. Renal recovery following acute kidney injury. Curr Opin Crit Care 2008; 14: 660-665
55. Ouellette AJ, Malt RA, Sukhatme VP et al. Expression of two immediate early genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 1990; 85: 766-771
56. Eckes B, Kessler D, Aumailley M et al. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer Semin Immunopathol 1999; 21: 415-429
57. Poulsom R, Forbes SJ, Hodivala-Dilke K et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 2001; 195: 229-235
58. Lin F, Cordes K, Li L et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14: 1188-1199
59. Duffield JS, Bonventre JV. Kidney tubular epithelium is restored without replacement with bone marrow-derived cells during repair after ischemic injury. Kidney Int 2005; 68: 1956-1961
60. Lin F, Moran A, Igarashi P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 2005; 115: 1756-1764
61. Bou-Gharios G, Garrett LA, Rossert J et al. A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 1996; 134: 1333-1344.